Humana Inc. Elects Robert S. Field to Board of Directors
On April 10, 2026, Humana Inc. announced that Robert S. Field has been elected to the Company's Board of Directors, effective immediately following the 2026 Annual Meeting of Stockholders. The Board's size was expanded from ten to eleven directors to accommodate this appointment. Mr. Field, who is the Principal and Managing Member of Ξ·Med Capital Management LLC, brings extensive experience in healthcare investment and strategy. The Board has determined that Mr. Field meets the independence standards set by the New York Stock Exchange. He will be compensated according to the Company's standard director compensation program, which includes an award of restricted stock units (RSUs). Mr. Field's background includes previous roles as a senior analyst at Luxor Capital and as an associate at McKinsey & Company, with prior experience in antitrust law. His appointment is part of the Company's ongoing commitment to Board refreshment and strong corporate governance, informed by shareholder engagement.